The following table sets forth information on outstanding option and stock awards held by the named executive officers of the Company on December 31, 2021, and December 31, 2020, including the number of shares underlying both exercisable and un-exercisable portions of each stock option as well as the exercise price and the expiration date of each outstanding option. See Note to Notes to Consolidated Financial Statements.
|
Outstanding Equity Awards After Fiscal Year-End (1)
|
|
Name
|
|
Number of securities underlying unexercised
options exercisable (1)
|
|
|
|
Number of securities underlying unexercised
options un-exercisable (2)
|
|
|
Option Exercise Price ($)
|
|
|
Option Grant Date
|
|
|
Option Expiration Date
|
|
Mikael Mildebrandt
|
|
|
3,704 |
|
(3)(4)
|
|
|
8 |
|
|
$
|
.001 |
|
|
11/01/2019 |
|
|
11/01/2023 |
|
Adrian Balinski
|
|
|
3,704 |
|
(3)(4)
|
|
|
8 |
|
|
$
|
.001 |
|
|
11/01/2019 |
|
|
11/01/2023 |
| | (1) | 7,408 shares were issued for Equity Awards during the year ended December 31, 2020. |
| | (2) | All options vest 20% per year beginning on the first anniversary of their grant date. | | | (3) | Messrs. Mildebrandt and Balinski were each awarded 3,704 shares of restricted common stock as of October 31, 2020, for being officers and directors of the Company. | | | (4) | Messer’s. Mildebrandt and Balinski have resigned as officers and directors. |
|